References
- Eurostat [Internet]. Population structure and ageing. [cited 2023 Feb 1]. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Population_structure_and_ageing.
- Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis. 2002 Nov;2(11):659–666. doi: 10.1016/s1473-3099(02)00437-1
- Yoshikawa TT. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis. 2000 Jun;30(6):931–933. doi: 10.1086/313792
- Dos Santos G, Tahrat H, Bekkat-Berkani R. Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: a systematic review. Hum Vaccin Immunother. 2018;14(8):1853–1866. doi: 10.1080/21645515.2018.1446719
- Berbudi A, Rahmadika N, Tjahjadi AI, et al. Type 2 diabetes and its impact on the immune System. Curr Diabetes Rev. 2020;16(5):442–449. doi: 10.2174/1573399815666191024085838
- Macounová P, Ar RM. Vaccines recommended for diabetic patients. Vnitr Lek. 2020;66(5):301–307. Spring English. doi: 10.36290/vnl.2020.085
- Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012 Jan;67(1):71–79. Epub 2010 Aug 20. doi: 10.1136/thx.2009.129502
- Henrichsen J. Six newly recognized types of streptococcus pneumoniae. J Clin Microbiol. 1995 Oct;33(10):2759–2762. doi: 10.1128/jcm.33.10.2759-2762.1995
- Wyplosz B, Fernandes J, Goussiaume G, et al. Adults at risk of pneumococcal disease in France. Infect Dis Now. 2021 Nov;51(8):661–666. Epub 2021 Jul 31. doi: 10.1016/j.idnow.2021.07.006
- Torres A, Blasi F, Dartois N, et al. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax. 2015 Oct;70(10):984–989. Epub 2015 Jul 28. doi: 10.1136/thoraxjnl-2015-206780
- Centers for Disease Control and Prevention [Internet]. About pneumococcal disease. Prevention. [2022 Jan 27; cited 2023 Feb 20]. Available from: https://www.cdc.gov/pneumococcal/about/prevention.html#:~:text=Vaccines%20are%20the%20best%20way%20to%20prevent%20pneumococcal%20disease
- Two New Pneumococcal Vaccines-Prevnar 20 and Vaxneuvance. JAMA. 2021 Dec 28;326(24):2521–2522. doi: 10.1001/jama.2021.22119
- Briles DE, Paton JC, Mukerji R, et al. Pneumococcal vaccines. Microbiol Spectr. 2019 Nov;7(6). doi: 10.1128/microbiolspec.GPP3-0028-2018
- U.S. Food and Drug Administration [Internet]. PNEUMOVAX 23 – Pneumococcal Vaccine, Polyvalent. [2021 Oct 28; cited 2023 Mar 1]. Available from: https://www.fda.gov/vaccines-blood-biologics/vaccines/pneumovax-23-pneumococcal-vaccine-polyvalent
- Pollard AJ, Perrett KP, Beverley PC. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat Rev Immunol. 2009 Mar;9(3):213–220. doi: 10.1038/nri2494
- Weinberger B. Vaccination of older adults: influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond. Immun Ageing. 2021 Oct 9;18(1):38. doi: 10.1186/s12979-021-00249-6
- European Centers for Disease Control and Prevention (ECDC). Pneumococcal Disease: Recommended vaccinations. [cited 2023 Feb 1]. Available from: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=-1
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71
- Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 Jun 15;21(11):1539–1558. doi: 10.1002/sim.1186
- Wells G, Shea B, O’Connel B, et al. The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2013 [cited 2023 Feb 1]. Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
- Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA. 1993 Oct 20;270(15):1826–1831. doi: 10.1001/jama.1993.03510150060030
- Sotiropoulos A, Koutsovasilis AG, Vergidou P, et al. Influenza and pneumococcal vaccination rates among Greek diabetes patients between 2003-2013 and its influence on their morbidity and hospitalization. Diabetes. 2015;64(Suppl.1):A441.
- Blinova E, Ignatova G, Antonov V. Effect of vaccination of pneumococcal infection on the course of chronic obstructive pulmonary disease in combination with diabetes mellitus. Eur Respir J. 2019 Sep;54(suppl 63):A4318. doi: 10.1183/13993003.congress-2019.PA4318
- Gilbertson DT, Guo H, Arneson TJ, et al. The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients. Nephrol Dial Transplant. 2011 Sep;26(9):2934–2939. Epub 2011 Feb 11. doi: 10.1093/ndt/gfq853
- Davis TME, Kauhanen J, Davis WA. Pneumococcal vaccination and incident hospitalisation for pneumonia in type 2 diabetes: the Fremantle Diabetes Study Phase II. Intern Med J. 2017 Oct;47(10):1206–1210. doi: 10.1111/imj.13569
- Kuo CS, Lu CW, Chang YK, et al. Effectiveness of 23-valent pneumococcal polysaccharide vaccine on diabetic elderly. Medicine (Baltimore). 2016 Jun;95(26):e4064. doi: 10.1097/MD.0000000000004064
- Jan IS, Tsai TH, Chen JM, et al. Hypoglycemia associated with bacteremic pneumococcal infections. Int J Infect Dis. 2009 Sep;13(5):570–576. Epub 2008 Dec 13. doi: 10.1016/j.ijid.2008.08.026
- Africano HF, Serrano-Mayorga CC, Ramirez-Valbuena PC, et al. Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease Are Serotype Dependent. Clin Infect Dis. 2021 Jun 1;72(11):e711–e719. doi: 10.1093/cid/ciaa1427
- Huss A, Scott P, Stuck AE, et al. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ. 2009 Jan 6;180(1):48–58. Erratum in: CMAJ. 2009 May 12;180(10):1038. doi: 10.1503/cmaj.080734
- Moberley S, Holden J, Tatham DP, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD000422. doi: 10.1002/14651858.CD000422.pub3
- van Aalst M, Lötsch F, Spijker R, et al. Incidence of invasive pneumococcal disease in immunocompromised patients: a systematic review and meta-analysis. Travel Med Infect Dis. 2018 Jul;24:89–100. doi: 10.1016/j.tmaid.2018.05.016
- Bechini A, Ninci A, Del Riccio M, et al. Impact of influenza vaccination on all-cause mortality and hospitalization for pneumonia in adults and the elderly with diabetes: a meta-analysis of observational studies. Vaccines (Basel). 2020 May 30;8(2):263. doi: 10.3390/vaccines8020263
- International Diabetes Federation (IDF). IDF Atlas [Internet]. IDF diabetes atlas 2022 reports. [cited 2023 Feb 1]. Available from: https://diabetesatlas.org/2022-reports/
- Vigezzi GP, Bertuccio P, Bossi CB, et al. COVID-19 pandemic impact on people with diabetes: results from a large representative sample of Italian older adults. Prim Care Diabetes. 2022 Oct;16(5):650–657. doi: 10.1016/j.pcd.2022.06.001
- Ota MOC, Badur S, Romano-Mazzotti L, et al. Impact of COVID-19 pandemic on routine immunization. Ann Med. 2021 Dec;53(1):2286–2297. doi: 10.1080/07853890.2021.2009128